Skip to main content
DNA logo

DNA · Ginkgo Bioworks Holdings, Inc. · Analyst Estimates

Track DNA — free
$12.34 -0.16 (-1.28%) At close · Oct 2
Market Cap
$844.45M
Shares
67.34M
Volume · Oct 2 2.04M Avg daily vol (3M) 1.38M

Analyst Estimates

Compare analyst forecasts for Ginkgo Bioworks Holdings, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 03:02 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-3.2
-3.2
-3.2
—
-3.42
-3.42
-3.42
-3.42
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
82200000
85033330
90000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
3
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-2.9
-2.9
-2.9
—
-3.21
-3.21
-3.21
-3.21
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
86700000
96400000
115000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
3
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.58
-0.58
-0.58
—
0.0
0.0
0.0
0.0
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
0
0
0
0
Revenue
USD
Publication date not stated
20500000
21576670
23030000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
3
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.82
-0.82
-0.82
—
0.0
0.0
0.0
0.0
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
0
0
0
0
Revenue
USD
Publication date not stated
22100000
23846670
27340000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
3
— — — — — — — —
Key facts CIK 1830214 CUSIP 37611X209 13F (30d) 2 filings 2 filers Visit website Investor relations